These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 26519881)
1. Critical role of ARID3B in the expression of pro-apoptotic p53-target genes and apoptosis. Pratama E; Tian X; Lestari W; Iseki S; Ichwan SJ; Ikeda MA Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):248-54. PubMed ID: 26519881 [TBL] [Abstract][Full Text] [Related]
2. Cooperation between ARID3A and p53 in the transcriptional activation of p21WAF1 in response to DNA damage. Lestari W; Ichwan SJ; Otsu M; Yamada S; Iseki S; Shimizu S; Ikeda MA Biochem Biophys Res Commun; 2012 Jan; 417(2):710-6. PubMed ID: 22172947 [TBL] [Abstract][Full Text] [Related]
3. Distinct and overlapping roles of ARID3A and ARID3B in regulating E2F‑dependent transcription via direct binding to E2F target genes. Saadat KASM; Lestari W; Pratama E; Ma T; Iseki S; Tatsumi M; Ikeda MA Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649863 [TBL] [Abstract][Full Text] [Related]
4. ARID3A and ARID3B exert direct regulatory control over the long non-coding RNAs (lncRNAs) MALAT1 and NORAD within the context of non-small cell lung cancer (NSCLC). Nasuh S; Balci SO; Bozgeyik I; Ikeda MA; Tekayev M; Saadat KASM Pathol Res Pract; 2023 Dec; 252():154948. PubMed ID: 37977034 [TBL] [Abstract][Full Text] [Related]
5. Chromium-mediated apoptosis: involvement of DNA-dependent protein kinase (DNA-PK) and differential induction of p53 target genes. Hill R; Leidal AM; Madureira PA; Gillis LD; Waisman DM; Chiu A; Lee PW DNA Repair (Amst); 2008 Sep; 7(9):1484-99. PubMed ID: 18602874 [TBL] [Abstract][Full Text] [Related]
6. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Seoane J; Le HV; Massagué J Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation by p53 and p73. Lokshin M; Tanaka T; Prives C Cold Spring Harb Symp Quant Biol; 2005; 70():121-8. PubMed ID: 16869745 [TBL] [Abstract][Full Text] [Related]
9. Tumor-derived mutations within the DNA-binding domain of p53 that phenotypically resemble the deletion of the proline-rich domain. Roth J; Koch P; Contente A; Dobbelstein M Oncogene; 2000 Mar; 19(14):1834-42. PubMed ID: 10777217 [TBL] [Abstract][Full Text] [Related]
10. Functional interplay between p53 and E2F through co-activator p300. Lee CW; Sørensen TS; Shikama N; La Thangue NB Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736 [TBL] [Abstract][Full Text] [Related]
11. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa. Valente LJ; Gray DH; Michalak EM; Pinon-Hofbauer J; Egle A; Scott CL; Janic A; Strasser A Cell Rep; 2013 May; 3(5):1339-45. PubMed ID: 23665218 [TBL] [Abstract][Full Text] [Related]
12. Sam68 functions as a transcriptional coactivator of the p53 tumor suppressor. Li N; Richard S Nucleic Acids Res; 2016 Oct; 44(18):8726-8741. PubMed ID: 27365047 [TBL] [Abstract][Full Text] [Related]
13. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function. Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999 [TBL] [Abstract][Full Text] [Related]
14. DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter. Liu H; Hew HC; Lu ZG; Yamaguchi T; Miki Y; Yoshida K Biochem J; 2009 Aug; 422(3):543-51. PubMed ID: 19558368 [TBL] [Abstract][Full Text] [Related]
15. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Phan RT; Dalla-Favera R Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913 [TBL] [Abstract][Full Text] [Related]
16. ZNF509S1 downregulates PUMA by inhibiting p53K382 acetylation and p53-DNA binding. Jeon BN; Yoon JH; Han D; Kim MK; Kim Y; Choi SH; Song J; Kim KS; Kim K; Hur MW Biochim Biophys Acta Gene Regul Mech; 2017 Sep; 1860(9):962-972. PubMed ID: 28757384 [TBL] [Abstract][Full Text] [Related]
17. YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription. Yakovleva T; Kolesnikova L; Vukojević V; Gileva I; Tan-No K; Austen M; Lüscher B; Ekström TJ; Terenius L; Bakalkin G Biochem Biophys Res Commun; 2004 May; 318(2):615-24. PubMed ID: 15120643 [TBL] [Abstract][Full Text] [Related]
18. LYG-202 inhibits the proliferation of human colorectal carcinoma HCT-116 cells through induction of G1/S cell cycle arrest and apoptosis via p53 and p21(WAF1/Cip1) expression. Liu W; Dai Q; Lu N; Wei L; Ha J; Rong J; Mu R; You Q; Li Z; Guo Q Biochem Cell Biol; 2011 Jun; 89(3):287-98. PubMed ID: 21491996 [TBL] [Abstract][Full Text] [Related]
19. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells. Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983 [TBL] [Abstract][Full Text] [Related]
20. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression. Zhang HM; Yuan J; Cheung P; Chau D; Wong BW; McManus BM; Yang D Mol Cell Biol; 2005 Jul; 25(14):6247-58. PubMed ID: 15988033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]